Sutro Biopharma (STRO) Short Interest Ratio & Short Volume

$4.12

-0.17 (-3.96%)

(As of 09/6/2024 ET)

Sutro Biopharma Short Interest Data

Sutro Biopharma (STRO) has a short interest of 3.39 million shares. This marks a 6.27% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.5, indicating that it would take 4.5 days of the average trading volume of 607,237 shares to cover all short positions.

Current Short Interest: 3,390,000 shares
Previous Short Interest: 3,190,000 shares
Change Vs. Previous Month: +6.27%
Dollar Volume Sold Short: $13.70 million
Short Interest Ratio: 4.5 Days to Cover
Last Record Date: August 15, 2024

Outstanding Shares: 81,960,000 shares
Percentage of Shares Shorted: 4.14%
Today's Trading Volume: 359,263 shares
Average Trading Volume: 607,237 shares
Today's Volume Vs. Average: 59%

Short Selling Sutro Biopharma?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Sutro Biopharma and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

STRO Short Interest Over Time

STRO Days to Cover Over Time

STRO Percentage of Float Shorted Over Time

Ad Golden Crest

Biden's Successor: The Radical Threat to YOUR Savings!

Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.

>> Get Your FREE Wealth Protection Guide <<

Sutro Biopharma Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/15/2024	3,390,000 shares	$13.70 million	+6.3%	N/A	4.5	$4.04
7/31/2024	3,190,000 shares	$12.66 million	-13.8%	N/A	3.9	$3.97
7/15/2024	3,700,000 shares	$15.61 million	+14.6%	N/A	4.5	$4.22
6/30/2024	3,230,000 shares	$9.46 million	+41.1%	N/A	3.8	$2.93
6/15/2024	2,290,000 shares	$7.92 million	+20.5%	N/A	2.3	$3.46
5/31/2024	1,900,000 shares	$8.03 million	-2.6%	N/A	1.9	$4.23
Get the Latest News and Ratings for STRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sutro Biopharma and its competitors with MarketBeat's FREE daily newsletter.
5/15/2024	1,950,000 shares	$7.66 million	No Change	N/A	1.9	$3.93
4/30/2024	1,950,000 shares	$6.62 million	-10.6%	N/A	2	$3.40
4/15/2024	2,180,000 shares	$9.03 million	-9.5%	N/A	2.2	$4.14
3/31/2024	2,410,000 shares	$13.62 million	+3.9%	N/A	2.3	$5.65
3/15/2024	2,320,000 shares	$9.54 million	-3.7%	N/A	2.6	$4.11
2/29/2024	2,410,000 shares	$11.83 million	-9.7%	N/A	2.9	$4.91
2/15/2024	2,670,000 shares	$11.99 million	+2.3%	N/A	3.2	$4.49
1/31/2024	2,610,000 shares	$11.33 million	+8.8%	N/A	2.9	$4.34
1/15/2024	2,400,000 shares	$9.60 million	+1.7%	N/A	2.7	$4.00
12/31/2023	2,360,000 shares	$10.12 million	+24.2%	N/A	2.6	$4.29
12/15/2023	1,900,000 shares	$7.56 million	-8.2%	N/A	2.4	$3.98
11/30/2023	2,070,000 shares	$5.40 million	-10.0%	N/A	3	$2.61
11/15/2023	2,300,000 shares	$5.66 million	-3.0%	N/A	3.7	$2.46
10/31/2023	2,370,000 shares	$6.52 million	-4.4%	N/A	5.3	$2.75
10/15/2023	2,480,000 shares	$9.77 million	+5.1%	N/A	6.2	$3.94
9/30/2023	2,360,000 shares	$8.19 million	-2.5%	N/A	6.3	$3.47
9/15/2023	2,420,000 shares	$9.46 million	+28.7%	N/A	7.9	$3.91
8/31/2023	1,880,000 shares	$8.93 million	-2.1%	N/A	4.5	$4.75
8/15/2023	1,920,000 shares	$8.20 million	-1.5%	N/A	4.5	$4.27
7/31/2023	1,950,000 shares	$8.72 million	-1.5%	N/A	4.3	$4.47
7/15/2023	1,980,000 shares	$9.37 million	+2.1%	N/A	4	$4.73
6/30/2023	1,940,000 shares	$9.02 million	-36.8%	N/A	3.8	$4.65
6/15/2023	3,070,000 shares	$16.61 million	+2.0%	N/A	5.6	$5.41
5/31/2023	3,010,000 shares	$13.51 million	-2.9%	N/A	6.2	$4.49
5/15/2023	3,100,000 shares	$18.23 million	+4.4%	N/A	6.6	$5.88
4/30/2023	2,970,000 shares	$12.65 million	-2.3%	N/A	6.5	$4.26
4/15/2023	3,040,000 shares	$13.38 million	+8.6%	N/A	7.1	$4.40
3/31/2023	2,800,000 shares	$12.94 million	+77.2%	N/A	5.5	$4.62
3/15/2023	1,580,000 shares	$8.53 million	-16.0%	N/A	2.9	$5.40
2/28/2023	1,880,000 shares	$10.60 million	+0.5%	N/A	3.3	$5.64
2/15/2023	1,870,000 shares	$11.61 million	-3.6%	N/A	3.3	$6.21
1/31/2023	1,940,000 shares	$14.05 million	-8.1%	N/A	3.4	$7.24
1/15/2023	2,110,000 shares	$16.61 million	+8.2%	N/A	3.6	$7.87
12/30/2022	1,950,000 shares	$15.76 million	-22.9%	N/A	3.7	$8.08
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover
12/15/2022	2,530,000 shares	$18.60 million	-4.2%	N/A	5.3	$7.35
11/30/2022	2,640,000 shares	$19.77 million	-30.7%	N/A	6.9	$7.49
11/15/2022	3,810,000 shares	$27.93 million	-8.2%	N/A	10.7	$7.33
10/31/2022	4,150,000 shares	$30.42 million	+0.2%	9.2%	12.6	$7.33
10/15/2022	4,140,000 shares	$23.14 million	+2.7%	9.2%	11.3	$5.59
9/30/2022	4,030,000 shares	$22.37 million	-5.0%	8.9%	11.3	$5.55
9/15/2022	4,240,000 shares	$24.34 million	-11.3%	9.4%	5.8	$5.74
8/31/2022	4,780,000 shares	$27.05 million	-7.9%	10.8%	5.8	$5.66
8/15/2022	5,190,000 shares	$36.90 million	+7.7%	11.7%	5.7	$7.11
7/31/2022	4,820,000 shares	$28.20 million	-1.0%	12.1%	5	$5.85
7/15/2022	4,870,000 shares	$28.49 million	-12.7%	12.7%	5	$5.85
6/30/2022	5,580,000 shares	$29.07 million	+22.1%	14.6%	5.8	$5.21
6/15/2022	4,570,000 shares	$17.55 million	+33.2%	11.9%	7.3	$3.84
5/31/2022	3,430,000 shares	$14.92 million	+7.9%	9.0%	6.1	$4.35
5/15/2022	3,180,000 shares	$14.63 million	+49.3%	8.3%	6.5	$4.60
4/30/2022	2,130,000 shares	$12.80 million	+17.0%	5.9%	4.5	$6.01
4/15/2022	1,820,000 shares	$13.21 million	+9.0%	5.1%	3.7	$7.26
3/31/2022	1,670,000 shares	$13.73 million	+31.5%	4.7%	3.3	$8.22
3/15/2022	1,270,000 shares	$10.29 million	-15.9%	3.5%	2.2	$8.10
2/28/2022	1,510,000 shares	$13.47 million	-0.7%	4.2%	2.8	$8.92
2/15/2022	1,520,000 shares	$13.77 million	-9.5%	4.2%	2.8	$9.06
1/31/2022	1,680,000 shares	$17.94 million	-17.2%	4.6%	3.2	$10.68
1/15/2022	2,030,000 shares	$21.72 million	-13.6%	5.6%	4.8	$10.70
12/31/2021	2,350,000 shares	$34.97 million	+3.1%	N/A	6.4	$14.88
12/15/2021	2,280,000 shares	$35.23 million	+34.9%	6.3%	9.4	$15.45
11/30/2021	1,690,000 shares	$28.87 million	+3.7%	4.7%	7.3	$17.08
11/15/2021	1,630,000 shares	$31.21 million	-14.2%	4.5%	7.7	$19.15
10/29/2021	1,900,000 shares	$38.30 million	-1.0%	5.3%	8.8	$20.16
10/15/2021	1,920,000 shares	$36.46 million	-9.0%	5.3%	8.1	$18.99
9/30/2021	2,110,000 shares	$39.86 million	-16.6%	5.8%	8.1	$18.89
9/15/2021	2,530,000 shares	$50.57 million	-10.3%	7.0%	8.2	$19.99
8/31/2021	2,820,000 shares	$61.25 million	-2.1%	7.8%	8.3	$21.72
8/13/2021	2,880,000 shares	$54.40 million	-2.4%	8.0%	7.9	$18.89
7/30/2021	2,950,000 shares	$50.24 million	-0.3%	8.1%	7.3	$17.03
7/15/2021	2,960,000 shares	$51.56 million	-3.6%	8.3%	7.4	$17.42
6/30/2021	3,070,000 shares	$57.07 million	-9.4%	8.6%	7.4	$18.59
6/15/2021	3,390,000 shares	$62.00 million	-3.4%	9.5%	7.9	$18.29
5/28/2021	3,510,000 shares	$65.32 million	-4.9%	9.9%	7.4	$18.61
5/14/2021	3,690,000 shares	$69.48 million	No Change	N/A	7.5	$18.83
4/30/2021	3,690,000 shares	$77.16 million	No Change	N/A	7.7	$20.91
4/15/2021	3,690,000 shares	$73.50 million	+4.2%	N/A	7.1	$19.92
3/31/2021	3,540,000 shares	$74.48 million	+139.2%	N/A	6.4	$21.04
3/15/2021	1,480,000 shares	$34.65 million	+29.8%	N/A	2.6	$23.41
2/26/2021	1,140,000 shares	$24.77 million	+10.7%	N/A	1.8	$21.73
2/12/2021	1,030,000 shares	$24.74 million	+12.5%	N/A	1.6	$24.02
1/29/2021	916,000 shares	$20.43 million	-19.7%	N/A	1.4	$22.30
1/15/2021	1,140,000 shares	$29.56 million	+1.8%	N/A	1.9	$25.93
12/31/2020	1,120,000 shares	$24.45 million	+85.3%	N/A	2.1	$21.83
12/15/2020	604,400 shares	$13.13 million	-75.6%	N/A	1.2	$21.73
11/30/2020	2,480,000 shares	$42.41 million	-4.6%	N/A	5	$17.10
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover
11/15/2020	2,600,000 shares	$44.80 million	-1.5%	N/A	6.9	$17.23
10/30/2020	2,640,000 shares	$34.87 million	-0.8%	N/A	6.8	$13.21
10/15/2020	2,660,000 shares	$32.53 million	-0.8%	N/A	7.8	$12.23
9/30/2020	2,680,000 shares	$26.93 million	+100.0%	N/A	7.9	$10.05
9/15/2020	1,340,000 shares	$14.94 million	+78.1%	N/A	3.9	$11.15
8/31/2020	752,300 shares	$7.53 million	+3.9%	3.3%	2.6	$10.01
8/14/2020	724,100 shares	$6.15 million	-5.6%	3.2%	3.9	$8.49
7/31/2020	767,300 shares	$5.96 million	-3.3%	N/A	4.6	$7.77
7/15/2020	793,500 shares	$6.94 million	+11.5%	3.5%	4.9	$8.74
6/30/2020	711,600 shares	$5.60 million	+450.8%	3.1%	4.8	$7.87
6/15/2020	129,200 shares	$1.15 million	+101.6%	0.6%	1.2	$8.88
5/29/2020	64,100 shares	$615,360.00	+3.9%	0.4%	0.8	$9.60
5/15/2020	61,700 shares	$556,534.00	-28.1%	0.4%	0.9	$9.02
4/30/2020	85,800 shares	$845,130.00	+46.2%	0.7%	2.1	$9.85
4/15/2020	58,700 shares	$588,761.00	-6.1%	0.6%	1.3	$10.03
3/31/2020	62,500 shares	$690,625.00	-9.3%	0.7%	1.1	$11.05
3/13/2020	68,900 shares	$692,445.00	+53.8%	0.8%	2.9	$10.05
2/28/2020	44,800 shares	$388,416.00	+1.6%	0.5%	0.7	$8.67
2/14/2020	44,100 shares	$399,105.00	-4.6%	0.5%	0.6	$9.05
1/31/2020	46,200 shares	$464,772.00	-12.2%	0.5%	0.6	$10.06
1/15/2020	52,600 shares	$620,680.00	+16.4%	0.6%	0.9	$11.80
12/31/2019	45,200 shares	$502,172.00	-69.0%	0.5%	0.8	$11.11

STRO Short Interest - Frequently Asked Questions

What is Sutro Biopharma's current short interest?: Short interest is the volume of Sutro Biopharma shares that have been sold short but have not yet been closed out or covered. As of August 15th, traders have sold 3,390,000 shares of STRO short. Learn More on Sutro Biopharma's current short interest.
What is a good short interest ratio for Sutro Biopharma?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. STRO shares currently have a short interest ratio of 4.0. Learn More on Sutro Biopharma's short interest ratio.
Is Sutro Biopharma's short interest increasing or decreasing?: Sutro Biopharma saw a increase in short interest in August. As of August 15th, there was short interest totaling 3,390,000 shares, an increase of 6.3% from the previous total of 3,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
How does Sutro Biopharma's short interest compare to its competitors?: Here is how the short interest of companies in the sector of "medical" compare to Sutro Biopharma: NewAmsterdam Pharma (4.31%), Avadel Pharmaceuticals plc (12.25%), Ardelyx, Inc. (11.16%), Longboard Pharmaceuticals, Inc. (14.47%), Cassava Sciences, Inc. (36.85%), Ocular Therapeutix, Inc. (12.12%), Centessa Pharmaceuticals plc (1.46%), Sana Biotechnology, Inc. (26.20%), ANI Pharmaceuticals, Inc. (7.96%), Evotec SE (0.08%),

Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks.
What does it mean to sell short Sutro Biopharma stock?: Short selling STRO is an investing strategy that aims to generate trading profit from Sutro Biopharma as its price is falling. STRO shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Sutro Biopharma?: A short squeeze for Sutro Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of STRO, which in turn drives the price of the stock up even further.
How often is Sutro Biopharma's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STRO, twice per month. The most recent reporting period available is August, 15 2024.